Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

1.85
Delayed Data
As of 4:00pm ET
 +0.025 / +1.37%
Today’s Change
1.60
Today|||52-Week Range
24.00
-87.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$65.4M

Company Description

Versartis, Inc. engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.

Contact Information

Versartis, Inc.
4200 Bohannon Drive
Menlo Park California 94025
P:(650) 963-8580
Investor Relations:
(650) 516-2703

Employees

Shareholders

Individual stakeholders41.41%
Other institutional31.93%
Mutual fund holders18.21%

Top Executives

Jay P. ShepardPresident, Chief Executive Officer & Director
Joshua T. BrummChief Operating & Financial Officer
Robert GutChief Medical Officer, Head-Clinical & Medical
Paul B. WestbergChief Business Officer & Senior Vice President
Shane M. WardSenior Vice President & General Counsel